Search for: "NV Organon"
Results 1 - 7
of 7
Sorted by Relevance
|
Sort by Date
4 Mar 2011, 6:12 am
Judge Sippel held a case management conference on February 14, 2011 at 3:30 p.m. wherein Plaintiffs addressed the possibility of naming an additional defendant, NV Organon. [read post]
16 Jan 2013, 3:41 pm
The outcome of the first trials could determine whether NV Organon and Merck will try to settle with plaintiffs rather than risk having to pay larger damages that are decided by a jury. [read post]
20 Apr 2010, 5:07 pm
The lawsuit complaints allege that the parties named as defendants, which includes Organon USA, Inc., Organon Pharmaceuticals USA, Inc., Organon International, Inc., Akzo Nobel NV, Organon Biosciences, N.V., and Schering-Plough Corporation, not only knew about the potential side effects associated with NUVARING®, but concealed those risks from the public, including the FDA during the approval process. [read post]
17 Dec 2007, 10:14 am
The defendants included Akzo Nobel NV, a Dutch company, and its Organon subsidiary, which has its principal place of business in New Jersey. [read post]
3 Nov 2011, 10:44 am
MANUFACTURERS: Organon Pharmaceuticals USA Inc., Organon USA Inc., Organon International Inc., Schering Plough Corp., and Akzo Nobel NV. [read post]
18 Feb 2012, 9:11 am
., Organon Pharmaceuticals, Akzo Nobel NV and Schering-Plough Corporation as defendants. [read post]
6 Apr 2011, 12:18 am
Laboratorios Rubió (EPLAW) Gemzar (Gemcitabine) – US: ITC: Target date of 23 July 2012 set in Certain Gemcitabine (ITC 337 Law Blog) Intuniv (Guanfacine) – US: Shire files patent infringement complaint based on Mylan’s ANDA filing (Patent Docs) Isentress (Raltegravir) – India: Cipla files for compulsory license against Merck’s Isentress (Spicy IP) Losartan, HCTZ – France: Cour d’appel confirms combination products infringe mono-SPCs and sets… [read post]
